Similar sites
Category
N/AGlobal Rank
N/ARank in 1 month
0Estimate Value
N/ABiosil | Advanced natural collagen generator
#biosil before and after pictures
#moisturizing gloves
#diet candy
#celebrities with hashimoto's
#estrosense
#policosanol
#maca for energy
#sytrinol
#sublingual b12
#boric acid suppositories
#white flower oil
#b12 sublingual
Category
N/AGlobal Rank
N/ARank in 1 month
0Estimate Value
N/A
#индометацин мазь
#гидрокортизон
#тербинафин мазь
#гидрокортизоновая мазь
#диклофенак мазь
#levomycetin
#фенибут
#метронидазол
#nistatin
#ацетилсалициловая кислота
#парацетамол детям дозировка
#парацетамол от чего
#парацетамол инструкция
#метоклопрамид
#сульфацил натрия
#тиосульфат натрия
#диклофенак гель
#диклофенак натрия
#эритромицин мазь глазная
#амброксол
#азитромицин
#парацетамол
#цитрамон
#гидрокортизон мазь
Category
N/AGlobal Rank
N/ARank in 1 month
0Estimate Value
N/AWelcome | Biosimilars Medical Academy
Category
N/AGlobal Rank
N/ARank in 1 month
0Estimate Value
N/ADigital Solutions and Services for Laboratories - BioSistemika
#rt pcr vs pcr
#real time pcr
#pcr melt curve
#rt pcr
#lea harrington
#primer design
#real-time pcr
#real time pcr principle
#qpcr machine price comparison
#cq value
#cloud based eln
Category
N/AGlobal Rank
N/ARank in 1 month
0Estimate Value
N/A
#bpcia litigation jury trial
#biosimilar market
#rituximab market
#biosimilar development
#biologics market
#biosimilars
#amgen biosimilars
#biosimilar
#amgen biosimilar
#biosimilar filing
#purple book
#neulasta biosimilar
#polpharma biologics
#rituximab biosimilar
#fulphila
#fda rejects
#biosimilar action plan
#vytorin generic
#vancomycin
#vytorin
#gralise
#gralise generic
#recombinant proteins market prnewswire marketsandmarkets
#life science trade shows 2018
Category
N/AGlobal Rank
N/ARank in 1 month
0Estimate Value
N/A
#biosimilar filing
#purple book
#neulasta biosimilar
#bpcia litigation jury trial
#biosimilar market
#rituximab market
#biosimilar development
#biologics market
#remicade patent expiry date
#biosimilar approvals
#apotex pegfilgrastim
#top selling biologics
Malware Scan Info
Macafee Check :
Email address with biosimilars.stada
Recent Searched Sites
Funayo.jp (29 seconds ago) / JP
Satyainternational.net (1 seconds ago) / US
Etirarx.com (1 mins ago) / US
Fairfield-inn-provo.ibooked.ca (8 seconds ago) / US
Northcote-hotel-scarborough.hotelmix.co.uk (5 seconds ago) / US
Angebdesigns.com (16 seconds ago) / US
Riviera-hotel-dubai.ibooked.ca (1 mins ago) / US
Beryezovskiy.stolplit.ru (17 seconds ago) / RU
Bronn.kr (15 seconds ago) / KR
Tre-box2.com (8 seconds ago) / JP
Contact-forms-builder.softonic-id.com (1 mins ago) / SE
57719.flowhot.cc (3 seconds ago) / US
Xiudajin.com (18 seconds ago) / VG
Parmashooting-range.com (34 seconds ago) / US
Atlantis.argofinance.money (1 mins ago) / US
Leshotelsdebeauval.com (29 seconds ago) / IE
Zagotov.ru (24 seconds ago) / RU
Biosimilars.stada (1 seconds ago) / GB
Four-seasons-jakarta-id-1.hotelmix.id (16 seconds ago) / US
Ibis-barcelona-pza-glories-22-hotel.ibooked.gr (7 seconds ago) / US
Domain Informations
Domain Provider | Number Of Domains |
---|---|
godaddy.com | 682459 |
namecheap.com | 226280 |
networksolutions.com | 167026 |
tucows.com | 138054 |
publicdomainregistry.com | 86591 |
whois.godaddy.com | 62081 |
enomdomains.com | 58049 |
cloudflare.com | 51575 |
namesilo.com | 48435 |
gmo.jp | 46514 |
register.com | 38825 |
fastdomain.com | 38013 |
ionos.com | 33965 |
wildwestdomains.com | 32128 |
name.com | 31938 |
registrar.amazon.com | 30730 |
net.cn | 30663 |
dynadot.com | 28794 |
key-systems.net | 27094 |
Host Informations
Host name | 185.217.43.20.srvlist.ukfast.net |
IP address | 185.217.43.20 |
Location | United Kingdom |
Latitude | 51.4964 |
Longitude | -0.1224 |
Timezone | Europe/London |
Port Scanner (IP: 185.217.43.20)
Spam Check (IP: 185.217.43.20) › Dnsbl-1.uceprotect.net:
› Dnsbl-2.uceprotect.net:
› Dnsbl-3.uceprotect.net:
› Dnsbl.dronebl.org:
› Dnsbl.sorbs.net:
› Spam.dnsbl.sorbs.net:
› Bl.spamcop.net:
› Recent.dnsbl.sorbs.net:
› All.spamrats.com:
› B.barracudacentral.org:
› Bl.blocklist.de:
› Bl.emailbasura.org:
› Bl.mailspike.org:
› Bl.spamcop.net:
› Cblplus.anti-spam.org.cn:
› Dnsbl.anticaptcha.net:
› Ip.v4bl.org:
› Fnrbl.fast.net:
› Dnsrbl.swinog.ch:
› Mail-abuse.blacklist.jippg.org:
› Singlebl.spamgrouper.com:
› Spam.abuse.ch:
› Spamsources.fabel.dk:
› Virbl.dnsbl.bit.nl:
› Cbl.abuseat.org:
› Dnsbl.justspam.org:
› Zen.spamhaus.org:
Keyword Suggestion
Site Inspections
Websites Listing
We found Websites Listing below when search with biosimilars.stada on Search Engine
Biosimilars | STADA
Auch STADA ist im Bereich Biosimilars aktiv und unterstützt als Gründungsmitglied die „Arbeitsgemeinschaft Pro Biosimilars“ – eine Interessensvertretung der …
Stada.deDA: 12 PA: 21 MOZ Rank: 33
Stada Launches Bevacizumab Biosimilar
Stada Arzneimittel has received European Commission approval for the bevacizumab biosimilar Oyavas and has immediately launched the product in Germany and …
Centerforbiosimilars.comDA: 28 PA: 43 MOZ Rank: 72
Alvotech and STADA agree on strategic biosimilar …
06/11/2019. Press Release. Alvotech and STADA enter into a strategic collaboration for seven biosimilar candidates in Europe. STADA will exclusively commercialise the …
Stada.comDA: 13 PA: 50 MOZ Rank: 48
Strategic Biosimilar Development Partnership: STADA and …
STADA and Xbrane have already entered into a co-development agreement for Xlucane, a Lucentis ® (ranibizumab) biosimilar, in July 2018. The agreement contains that …
Stada.comDA: 13 PA: 50 MOZ Rank: 47
The Next-Generation Biosimilar Race: A Tale of Two …
USTEKINUMAB (STELARA®) BIOSIMILARS IN DEVELOPMENT. The main patent for Stelara expires in September 2023 in the US (January 2024 in Europe). Whereas the US …
Biosimilarsrr.comDA: 17 PA: 50 MOZ Rank: 46
Stada to Invest $115 Million in Biosimilar Development
Stada, a biopharmaceutical company based in Germany, recently announced that it is increasing its presence in the biosimilar sphere by becoming the majority shareholder in …
Centerforbiosimilars.comDA: 28 PA: 50 MOZ Rank: 92
Strategic Biosimilar Development Partnership: STADA and Xbrane ...
STADA and Xbrane have already entered into a co-development agreement for Xlucane, a Lucentis® (ranibizumab) biosimilar in July 2018. The agreement contains that both …
Xbrane.comDA: 10 PA: 50 MOZ Rank: 44
Strategic Biosimilar Development Partnership: STADA and Xbrane ...
Bad Vilbel, May 31, 2019 – STADA Arzneimittel AG and Xbrane Biopharma AB have expanded their strategic biosimilar development partnership. This allows both …
Stada-apac.comDA: 18 PA: 50 MOZ Rank: 43
Stada in-licenses teriparatide biosimilar - GaBI Online
German generics giant Stada Arzneimittel (Stada) announced on 13 October 2014 that it had made a deal to in-licensing a teriparatide biosimilar. Generics and biosimilar …
Gabionline.netDA: 18 PA: 50 MOZ Rank: 85
STADA sets up for success with Erin Federman | STADA
Bad Vilbel, 5 January 2022 – STADA is from 3 January 2022 strengthening its biosimilars capabilities with the appointment of Erin Federman as Global Commercial Head, …
Stada.comDA: 13 PA: 50 MOZ Rank: 41
Director (f/m/d) Global Biosimilars Commercial Development
Bad Vilbel Director (f/m/d) Global Biosimilars Commercial Development - HE, 61118 ... At STADA we pursue our purpose “Caring for people‘s health as a trusted partner” worldwide. …
Jobs.stada.comDA: 14 PA: 35 MOZ Rank: 59
STADA strengthens oncology offering by launching bevacizumab
STADA CEO Peter Goldschmidt: “Introducing bevacizumab is testament to STADA’s strategy of being a go-to-partner for enabling patient access to biosimilars in …
Stada.comDA: 13 PA: 50 MOZ Rank: 39
Über Biosimilars | biosimilars
2008 hat STADA als eines der ersten Unternehmen ein Biosimilar auf den Markt gebracht. Inzwischen verfügen wir über ein ganzes Portfolio mit Biosimilars für unterschiedliche …
De.biosimilars.stadaDA: 24 PA: 34 MOZ Rank: 70
STADA in-licenses teriparatide and further expands biosimilar …
Bad Vilbel, October 13, 2014 –. STADA Arzneimittel AG in-licenses teriparatide and thereby once again expands its biosimilar portfolio. The teriparatide biosimilar is being …
Stada-mena.comDA: 18 PA: 50 MOZ Rank: 37
STADA, Xbrane Ranibizumab Candidate Meets Primary End Point …
STADA and Xbrane entered a codevelopment agreement for the biosimilar in July 2018 and per the terms of the agreement, will contribute equally to the development costs and …
Centerforbiosimilars.comDA: 28 PA: 50 MOZ Rank: 36
En | STADA
STADA is a company with a focus on the healthcare market. Generics & Consumer Health Products. The foundation of STADA’s growth story rests on two pillars: generics, including …
Stada-apac.comDA: 18 PA: 18 MOZ Rank: 34
Alvotech and STADA Agree on Strategic Biosimilar Partnership
Alvotech and STADA Agree on One of the Largest Commercial Biosimilar Partnership to Date Contacts Alvotech Halldor Kristmannsson …
Businesswire.comDA: 20 PA: 50 MOZ Rank: 34
STADA Arzneimittel AG - Your Partner in Health | STADA
As STADA we are "Caring for people‘s health as a trusted partner". 125 years STADA. This year is a very special year for STADA: STADA Arzneimittel AG was founded 125 years ago! …
Stada-mena.comDA: 18 PA: 18 MOZ Rank: 36
Stada in-licenses biosimilar filgrastim
German generics giant Stada Arzneimittel (Stada) announced on 28 October 2013 that it was strengthening its activities in the biosimilars area by i... Generics and biosimilar Initiative …
Gabionline.netDA: 14 PA: 50 MOZ Rank: 32
STADA and Xbrane strengthen biosimilars collaboration
German generics giant Stada Arzneimittel (Stada) and Swedish biotech company Xbrane Bioscience (Xbrane) announced on 31 May 2019 that they have exp... Generics and …
Gabionline.netDA: 18 PA: 50 MOZ Rank: 31
Domains Expiration Date Updated
Site | Provider | Expiration Date |
---|---|---|
studiomadane.com | godaddy.com | 7 Years, 292 Days |
tryangulate.com | enomdomains.com | 295 Days |
tokaijoker123.com | namecheap.com | 63 Days |
littlescholars.net | register.com | 361 Days |
silverstarreit.com | networksolutions.com | 1 Year, 56 Days |
hyperspaceprops.com | godaddy.com | 3 Years, 203 Days |
lapp4u.com | gabia.com | 2 Years, 304 Days |